January 16, 2020
Bigfoot Biomedical, a diabetes startup looking to automate insulin delivery via a connected insulin pen, has kicked off its Series C round with an initial tranche of $45 million. The raise is headed once again by Abbott, with prior backers Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management pitching in once again.
Alongside the news of its raise, Bigfoot...
July 17, 2019
Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning.
Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales...
May 2, 2017
The U.S. Department of Defense has picked Abbott Laboratories to develop a traumatic brain injury test in a one-bid contract.
Abbott has been working with DoD on similar projects that clinicians can use to conduct tests via mobile devices already in place since at least 2014. DoD put the new contract total at $11.3 million and said of that $2.5 million was obligated when it named Abbott.